Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR | 39 | 1 | 24 | 0 | €134.50 | €150.00 | 11.524% |
| Eli Lilly Corp. | 67 | 0 | 20 | 0 | €853.20 | €883.50 | 3.551% |
| AbbVie Inc. | 34 | 0 | 13 | 0 | €159.50 | €175.88 | 10.271% |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 11 | 0 | €979.00 | €1,046.4 | 6.880% |
| Roche Holding AG ADR | 12 | 2 | 10 | 1 | €32.61 | €38.25 | 17.284% |
| UnitedHealth Group Inc. | 39 | 1 | 9 | 0 | €455.05 | €540.17 | 18.707% |
| Thermo Fisher Scientific Inc. | 34 | 0 | 8 | 0 | €513.10 | €566.65 | 10.436% |
| GSK plc ADR | 11 | 0 | 8 | 0 | €36.20 | €42.25 | 16.713% |
| Sarepta Therapeutics | 8 | 0 | 7 | 0 | €147.55 | €190.00 | 28.770% |
| Johnson & Johnson | 38 | 1 | 6 | 0 | €136.58 | €187.15 | 37.028% |
| Vertex Pharmaceuticals Inc. | 52 | 2 | 6 | 0 | €442.80 | €432.21 | -2.392% |
| Boston Scientific | 52 | 0 | 5 | 0 | €72.50 | €75.15 | 3.657% |
| Cigna Corp. | 20 | 0 | 5 | 0 | €315.95 | €351.57 | 11.275% |
| Merck & Co. Inc. | 33 | 1 | 5 | 0 | €121.60 | €125.66 | 3.337% |
| HCA Holdings Inc. | 28 | 0 | 5 | 0 | €322.40 | €308.43 | -4.332% |
| Pfizer Inc. | 32 | 4 | 5 | 0 | €26.00 | €40.66 | 56.383% |
| Dexcom Inc. | 20 | 0 | 4 | 0 | €106.94 | €134.68 | 25.941% |
| Sanofi S.A. | 7 | 0 | 4 | 0 | €90.31 | €99.50 | 10.176% |
| Agilent Technologies Inc. | 14 | 4 | 4 | 1 | €122.24 | €131.48 | 7.563% |
| Gilead Sciences Inc | 15 | 1 | 4 | 0 | €64.51 | €79.54 | 23.303% |
| Biogen Inc. | 52 | 1 | 4 | 0 | €214.20 | €293.22 | 36.893% |
| Teva Pharmaceutical Industries Ltd ADR | 15 | 0 | 3 | 0 | €15.25 | €18.56 | 21.705% |
| Centene Corp. | 18 | 0 | 3 | 0 | €62.95 | €82.88 | 31.654% |
| Exact Sciences | 16 | 0 | 3 | 0 | €41.55 | €78.89 | 89.871% |
| Fresenius SE & Co. KGaA | 7 | 0 | 3 | 0 | €28.08 | €34.50 | 22.863% |